Long-Term Outcome of Surgical Treatment for Non-Small Cell Lung Cancer With Comorbid Liver Cirrhosis

Annals of Thoracic Surgery

Volumn 84, Issue 6, 2007, Pages 1810-1817

  Iwata, Takashi ^a   Inoue, Kiyotoshi ^a   Nishiyama, Noritoshi ^a   Nagano, Koshi ^a   Izumi, Nobuhiro ^a   Mizuguchi, Shinjiro ^a   Morita, Ryuhei ^a   Tsukioka, Takuma ^a   Suehiro, Shigefumi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BILIRUBIN; CHOLINESTERASE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; LIFE EXPECTANCY; LIVER CIRRHOSIS; LIVER FUNCTION; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; BILIRUBIN; CARCINOMA, NON-SMALL-CELL LUNG; CHOLINESTERASES; FEMALE; HUMANS; LIVER CIRRHOSIS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET COUNT; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 36248944602     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.07.030     Document Type: Article

References (30)

1. Zeniya M., and Nakajima H. Liver cirrhosis: statistics in Japan (in Japanese). Nippon Rinsho 60 Suppl 1 (2002) 233-241
2. Nishioka K. Hepatitis C virus infection in Japan. Gastroenterol Jpn 26 Suppl 3 (1991) 152-155
3. McCaughan G.W. Asian perspectives on viral hepatitis: hepatitis C virus infection. J Gastroenterol Hepatol 15 Suppl (2000) G90-G93
4. Edwards J.T., and Macdonald G.A. Hepatocellular carcinoma. Curr Opin Gastroenterol 16 (2000) 275-281
5. Yoshida H., Shiratori Y., Moriyama M., et al., IHIT Study Group. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. Inhibition of Hepatocarcinogenesis by Interferon Therapy. Ann Intern Med 131 (1999) 174-181
6. Ikeda K., Saitoh S., Arase Y., et al. Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis. Hepatology 29 (1999) 1124-1130
7. Okanoue T., Itoh Y., Minami M., et al., Viral Hepatitis Therapy Study Group. Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients. J Hepatol 30 (1999) 653-659
8. Ueda H., Iwasaki A., Kusano T., and Shirakusa T. Thoracotomy in patients with liver cirrhosis. Scand J Thorac Cardiovasc Surg 28 (1994) 37-41
9. Iwasaki A., Shirakusa T., Okabayashi K., et al. Lung cancer surgery in patients with liver cirrhosis. Ann Thorac Surg 82 (2006) 1027-1032
10. Pugh R.N., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., and Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60 (1973) 646-649
11. Lucey M.R., Brown K.A., Everson G.T., et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 3 (1997) 628-637
12. Nanashima A., Sumida Y., Morino S., et al. The Japanese integrated staging score using liver damage grade for hepatocellular carcinoma in patients after hepatectomy. Eur J Surg Oncol 30 (2004) 765-770
13. Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer. 2nd English ed. (2003), Kanehara, Tokyo
14. Sorensen H.T., Thulstrup A.M., Mellemkjar L., et al. Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark. J Clin Epidemiol 56 (2003) 88-93
15. Montalto G., Cervello M., Giannitrapani L., Dantona F., Terranova A., and Castagnetta L.A. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann NY Acad Sci 963 (2002) 13-20
16. Tanaka K., Sakai H., Hashizume M., and Hirohata T. A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis. Jpn J Cancer Res 89 (1998) 1241-1250
17. Isozaki H., Okajima K., Ichinona T., Fujii K., Nomura E., and Izumi N. Surgery for gastric cancer in patients with cirrhosis. Surg Today 27 (1997) 17-21
18. Ryu K.W., Lee J.H., Kim Y.W., Park J.W., and Bae J.M. Management of ascites after radical surgery in gastric cancer patients with liver cirrhosis and minimal hepatic dysfunction. World J Surg 29 (2005) 653-656
19. Lee J.H., Kim J., Cheong J.H., Hyung W.J., Choi S.H., and Noh S.H. Gastric cancer surgery in cirrhotic patients: result of gastrectomy with D2 lymph node dissection. World J Gastroenterol 11 (2005) 4623-4627
20. Carbo J., Garcia-Samaniego J., Castellano G., Iniguez A., and Solis-Herruzo J.A. Liver cirrhosis and mortality by abdominal surgery. A study of risk factors. Rev Esp Enferm Dig 90 (1998) 105-112
21. Lehnert T., and Herfarth C. Peptic ulcer surgery in patients with liver cirrhosis. Ann Surg 217 (1993) 338-346
22. Cryer H.M., Howard D.A., and Garrison R.N. Liver cirrhosis and biliary surgery: assessment of risk. South Med J 78 (1985) 138-141
23. Mansour A., Watson W., Shayani V., and Pickleman J. Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery 122 (1997) 730-736
24. Tanaka R., Itoshima T., and Nagashima H. Follow-up study of 582 liver cirrhosis patients for 26 years in Japan. Liver 7 (1987) 316-324
25. Yoneyama K., Yamaguchi M., Kiuchi Y., Morizane T., Shibata M., and Mitamura K. Analysis of background factors influencing long-term prognosis of patients with chronic hepatitis C treated with interferon. Intervirology 45 (2002) 11-19
26. Iino S. Relationship between infection with hepatitis C virus and hepatocellular carcinoma in Japan. Antivir Ther 3 (1998) 143-146
27. Filsoufi F., Salzberg S.P., Rahmanian P.B., et al. Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver Transpl 13 (2007) 990-995
28. An Y., Xiao Y.B., and Zhong Q.J. Open-heart surgery in patients with liver cirrhosis: indications, risk factors, and clinical outcomes. Eur Surg Res 39 (2007) 67-74
29. Lin C.H., Lin F.Y., Wang S.S., Yu H.Y., and Hsu R.B. Cardiac surgery in patients with liver cirrhosis. Ann Thorac Surg 79 (2005) 1551-1554
30. Ninomiya M., Takamoto S., Kotsuka Y., and Ohtsuka T. Indication and perioperative management for cardiac surgery in patients with liver cirrhosis. Our experience with 3 patients. Jpn J Thorac Cardiovasc Surg 49 (2001) 391-394